X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
Canada
0
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
24
PharmaCompass offers a list of Clavulanic Acid API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Clavulanic Acid manufacturer or Clavulanic Acid supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Clavulanic Acid manufacturer or Clavulanic Acid supplier.
PharmaCompass also assists you with knowing the Clavulanic Acid API Price utilized in the formulation of products. Clavulanic Acid API Price is not always fixed or binding as the Clavulanic Acid Price is obtained through a variety of data sources. The Clavulanic Acid Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Clavulanate Potassium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Clavulanate Potassium, including repackagers and relabelers. The FDA regulates Clavulanate Potassium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Clavulanate Potassium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Clavulanate Potassium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Clavulanate Potassium supplier is an individual or a company that provides Clavulanate Potassium active pharmaceutical ingredient (API) or Clavulanate Potassium finished formulations upon request. The Clavulanate Potassium suppliers may include Clavulanate Potassium API manufacturers, exporters, distributors and traders.
click here to find a list of Clavulanate Potassium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Clavulanate Potassium DMF (Drug Master File) is a document detailing the whole manufacturing process of Clavulanate Potassium active pharmaceutical ingredient (API) in detail. Different forms of Clavulanate Potassium DMFs exist exist since differing nations have different regulations, such as Clavulanate Potassium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Clavulanate Potassium DMF submitted to regulatory agencies in the US is known as a USDMF. Clavulanate Potassium USDMF includes data on Clavulanate Potassium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Clavulanate Potassium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Clavulanate Potassium suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Clavulanate Potassium Drug Master File in Korea (Clavulanate Potassium KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Clavulanate Potassium. The MFDS reviews the Clavulanate Potassium KDMF as part of the drug registration process and uses the information provided in the Clavulanate Potassium KDMF to evaluate the safety and efficacy of the drug.
After submitting a Clavulanate Potassium KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Clavulanate Potassium API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Clavulanate Potassium suppliers with KDMF on PharmaCompass.
A Clavulanate Potassium CEP of the European Pharmacopoeia monograph is often referred to as a Clavulanate Potassium Certificate of Suitability (COS). The purpose of a Clavulanate Potassium CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Clavulanate Potassium EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Clavulanate Potassium to their clients by showing that a Clavulanate Potassium CEP has been issued for it. The manufacturer submits a Clavulanate Potassium CEP (COS) as part of the market authorization procedure, and it takes on the role of a Clavulanate Potassium CEP holder for the record. Additionally, the data presented in the Clavulanate Potassium CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Clavulanate Potassium DMF.
A Clavulanate Potassium CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Clavulanate Potassium CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Clavulanate Potassium suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Clavulanate Potassium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Clavulanate Potassium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Clavulanate Potassium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Clavulanate Potassium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Clavulanate Potassium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Clavulanate Potassium suppliers with NDC on PharmaCompass.
Clavulanate Potassium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Clavulanate Potassium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Clavulanate Potassium GMP manufacturer or Clavulanate Potassium GMP API supplier for your needs.
A Clavulanate Potassium CoA (Certificate of Analysis) is a formal document that attests to Clavulanate Potassium's compliance with Clavulanate Potassium specifications and serves as a tool for batch-level quality control.
Clavulanate Potassium CoA mostly includes findings from lab analyses of a specific batch. For each Clavulanate Potassium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Clavulanate Potassium may be tested according to a variety of international standards, such as European Pharmacopoeia (Clavulanate Potassium EP), Clavulanate Potassium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Clavulanate Potassium USP).
Market Place
